Advertisement
Canada markets open in 3 hours 59 minutes

  • S&P/TSX

    21,873.72
    -138.00 (-0.63%)
     

  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     

  • DOW

    38,460.92
    -42.77 (-0.11%)
     

  • CAD/USD

    0.7312
    +0.0014 (+0.19%)
     

  • CRUDE OIL

    82.83
    +0.02 (+0.02%)
     

  • Bitcoin CAD

    87,604.06
    -3,264.19 (-3.59%)
     

  • CMC Crypto 200

    1,365.33
    -17.24 (-1.25%)
     

  • GOLD FUTURES

    2,338.20
    -0.20 (-0.01%)
     

  • RUSSELL 2000

    1,995.43
    -7.22 (-0.36%)
     

  • 10-Yr Bond

    4.6520
    +0.0540 (+1.17%)
     

  • NASDAQ futures

    17,514.00
    -150.50 (-0.85%)
     

  • VOLATILITY

    16.19
    +0.22 (+1.38%)
     

  • FTSE

    8,090.46
    +50.08 (+0.62%)
     

  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     

  • CAD/EUR

    0.6816
    -0.0003 (-0.04%)
     

Cytokinetics, Incorporated (CYTK) Jumps: Stock Up 13.5%

Zacks Equity Research

Cytokinetics, Incorporated (CYTK) was a big mover last session, as its shares rose nearly 14% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $8.51 to $9.90 in the past one-month timeframe.

In the last 30 days, the company did not witness any estimate revision and the Zacks Consensus Estimate also remained unchanged. Yesterday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Cytokinetics currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Other better-ranked stocks in the medical sector include TrovaGene, Inc. (TROV), ZIOPHARM Oncology, Inc. (ZIOP) and Biogen Idec Inc. (BIIB). All three sport a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>



BIOGEN IDEC INC (BIIB): Free Stock Analysis Report

ZIOPHARM ONCOLOGY INC (ZIOP): Free Stock Analysis Report

TROVAGENE NEW (TROV): Free Stock Analysis Report

CYTOKINETICS (CYTK): Free Stock Analysis Report


Zacks Investment Research